Phio Pharmaceuticals Corp. Banner Image

Phio Pharmaceuticals Corp. has reached its limit for free report views

Work for Phio Pharmaceuticals Corp.? Upgrade Your Profile and unlock all your annual reports.

Phio Pharmaceuticals Corp.

  • Ticker PHIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Phio Pharmaceuticals Corp. Logo Image
  • 11-50 Employees
  • Based in Marlborough, Massachusetts
Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYLâ„¢) therapeutic platform. The Company's efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environmentMore. Their goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities.
Phio Pharmaceuticals Corp.

Most Recent Annual Report

Phio Pharmaceuticals Corp. MOST RECENT 2019 Form 10K

Report Locked. Phio Pharmaceuticals Corp. has reached its limit for free report views.

Older/Archived Annual Reports